Chinese firm to build home-grown CT

Article

A Chinese company has begun building low-priced CT scanners, which could compete in the country for sales with systems marketed by such multinational vendors as Shimadzu, GE, and Siemens. Shenyang Neu-Alpine Software has been granted permission by the

A Chinese company has begun building low-priced CT scanners, which could compete in the country for sales with systems marketed by such multinational vendors as Shimadzu, GE, and Siemens. Shenyang Neu-Alpine Software has been granted permission by the State Pharmaceutical Administration Commission to begin mass production of CT scanners, according to Comline Computer Wire. The company is believed to be the first Chinese firm manufacturing its own CT scanners, according to sources familiar with the Chinese market.

The company plans to win market share by selling its scanners at a considerable price discount compared with products marketed by importers. Neu-Alpine Software's scanners will list at $192,700, while imported machines cost around $360,000, according to Comline. The company plans to manufacture 100 CT scanners annually.

Although the company's scanners will enjoy a major price advantage, Chinese companies do not have a stellar record in producing complex medical imaging machinery. Chinese manufacturers have been competing in MRI since the early 1990s, but have not taken a substantial share of the Chinese market, according to observers.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.